France
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
26.26%
|
Dec. 31, 2023 | USD 37.82 | -0.43% |
|
France |
|
2 |
26.04%
|
Dec. 31, 2023 | USD 125.57 | 1.43% |
|
France |
|
3 |
18.67%
|
Dec. 31, 2023 | USD 223.78 | 0.44% |
|
France |
|
4 |
17.86%
|
Dec. 31, 2023 | USD 107.78 | 1.15% |
|
France |
|
5 |
16.18%
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
6 |
12.01%
|
Dec. 31, 2023 | USD 121.52 | 0.77% |
|
France |
|
7 |
11.07%
|
June 30, 2024 | USD 3.56 | -2.04% |
|
France |
|
8 |
10.30%
|
Dec. 31, 2023 | USD 3.53 | -0.92% |
|
France |
|
9 |
9.74%
|
Dec. 31, 2023 | USD 26.48 | -1.30% |
|
France |
|
10 |
8.73%
|
Dec. 31, 2023 | USD 22.89 | 0.71% |
|
France |
|
11 |
7.88%
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
12 |
4.29%
|
Dec. 31, 2023 | USD 2.49 | 1.52% |
|
France |
|
13 |
3.16%
|
June 30, 2024 | USD 11.08 | 0.25% |
|
France |
|
14 |
2.94%
|
Dec. 31, 2023 | USD 12.48 | 0.25% |
|
France |
|
15 |
-22.76%
|
Dec. 31, 2023 | USD 3.27 | -1.63% |
|
France |
|
16 |
-24.41%
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
17 |
-48.99%
|
Dec. 31, 2023 | USD 3.21 | 17.34% |
|
France |
|
18 |
-54.30%
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
19 |
-74.20%
|
Dec. 31, 2023 | USD 1.27 | 1.92% |
|
France |
|
20 |
-83.63%
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
21 |
-93.61%
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
22 |
-105.12%
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
23 |
-151.00%
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
24 |
-170.22%
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
25 |
-205.08%
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
26 |
-240.83%
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
27 |
-532.90%
|
Dec. 31, 2023 | USD 1.58 | 0.91% |
|
France |
|
28 |
-598.32%
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
29 |
-923.35%
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
30 |
-925.09%
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
31 |
-944.14%
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
32 |
-1,058.87%
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
33 |
-2,897.94%
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
34 |
-8,137.93%
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
35 |
-14,723.05%
|
Dec. 31, 2023 | USD 1.61 | 2.90% |
|
France |
The Healthcare company in France with the highest EBIT Margin is Equasens SA (Paris Stock Exchange: EQS.PA) at 26.26%.
The Healthcare company in France with the lowest EBIT Margin is Cellectis S.A. (Paris Stock Exchange: ALCLS.PA) at -14,723.05%.
The top 10 Healthcare companies in France by EBIT Margin are Equasens SA, Ipsen S.A., Sartorius Stedim Biotech S.A., Sanofi, Eurofins-Cerep SA, bioMérieux S.A., Amplitude Surgical SA, genOway SA, Boiron SA and LNA Santé SA.
The bottom 10 Healthcare companies in France by EBIT Margin are Cellectis S.A., Crossject SA, ABIVAX SA, AB Science S.A., OSE Immunotherapeutics SA, MaaT Pharma SA, Adocia SA, Inventiva S.A., Ikonisys S.A. and Novacyt S.A..